These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 11117673)

  • 21. D-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review.
    Galazis N; Galazi M; Atiomo W
    Gynecol Endocrinol; 2011 Apr; 27(4):256-62. PubMed ID: 21142777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment.
    Højlund K; Glintborg D; Andersen NR; Birk JB; Treebak JT; Frøsig C; Beck-Nielsen H; Wojtaszewski JF
    Diabetes; 2008 Feb; 57(2):357-66. PubMed ID: 17977950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.
    Morgante G; Cappelli V; Di Sabatino A; Massaro MG; De Leo V
    Minerva Ginecol; 2015 Oct; 67(5):457-63. PubMed ID: 26491824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inositol as putative integrative treatment for PCOS.
    Genazzani AD
    Reprod Biomed Online; 2016 Dec; 33(6):770-780. PubMed ID: 27717596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the treatment with D-chiro-inositol on levels of oxidative stress in PCOS patients].
    De Leo V; La Marca A; Cappelli V; Stendardi A; Focarelli R; Musacchio MC; Piomboni P
    Minerva Ginecol; 2012 Dec; 64(6):531-8. PubMed ID: 23232537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome.
    Iuorno MJ; Jakubowicz DJ; Baillargeon JP; Dillon P; Gunn RD; Allan G; Nestler JE
    Endocr Pract; 2002; 8(6):417-23. PubMed ID: 15251831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reflections on inositol(s) for PCOS therapy: steps toward success.
    Nestler JE; Unfer V
    Gynecol Endocrinol; 2015 Jul; 31(7):501-5. PubMed ID: 26177098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myo-inositol vs. D-chiro inositol in PCOS treatment.
    Formuso C; Stracquadanio M; Ciotta L
    Minerva Ginecol; 2015 Aug; 67(4):321-5. PubMed ID: 25670222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
    Dhindsa G; Bhatia R; Dhindsa M; Bhatia V
    J Postgrad Med; 2004; 50(2):140-4. PubMed ID: 15235215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system.
    Nestler JE; Jakubowicz DJ; de Vargas AF; Brik C; Quintero N; Medina F
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2001-5. PubMed ID: 9626131
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Inositols in the Hyperandrogenic Phenotypes of PCOS: A Re-Reading of Larner's Results.
    Fedeli V; Catizone A; Querqui A; Unfer V; Bizzarri M
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inositol: history of an effective therapy for Polycystic Ovary Syndrome.
    Bizzarri M; Carlomagno G
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1896-903. PubMed ID: 25010620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach.
    Laganà AS; Garzon S; Casarin J; Franchi M; Ghezzi F
    Trends Endocrinol Metab; 2018 Nov; 29(11):768-780. PubMed ID: 30270194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?
    Corbould A
    Diabetes Metab Res Rev; 2008 Oct; 24(7):520-32. PubMed ID: 18615851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial.
    Gerli S; Mignosa M; Di Renzo GC
    Eur Rev Med Pharmacol Sci; 2003; 7(6):151-9. PubMed ID: 15206484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial.
    Unfer V; Carlomagno G; Rizzo P; Raffone E; Roseff S
    Eur Rev Med Pharmacol Sci; 2011 Apr; 15(4):452-7. PubMed ID: 21608442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of myo-inositol to reproduction.
    Papaleo E; Unfer V; Baillargeon JP; Chiu TT
    Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):120-3. PubMed ID: 19800728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ovarian insulin resistance and insulin sensitizer effect on polycystic ovary syndrome].
    Wu XK; Risto E
    Zhonghua Fu Chan Ke Za Zhi; 2004 Dec; 39(12):804-8. PubMed ID: 15733404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.